Please Note: This trial is no longer enrolling new participants
RANDOMIZED TRIAL OF STANDARD CHEMOTHERAPY ALONE OR COMBINED WITH ATEZOLIZUMAB AS ADJUVANT THERAPY FOR PATIENTS WITH STAGE III COLON CANCER AND DEFICIENT DNA MISMATCH REPAIR
| Protocol No. | A021502 | Scope | National |
|---|---|---|---|
| Principal Investigator | Patrick Loehrer | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase III |
